NAMPT and myocardial infarction: The AAR of myocardial infarction was comparable among the treatment groups (42.1 ± 2.0% in control versus 53.2 ± 8.0% visfatin, 53.6 ± 8.0% visfatin + wortmannin, 47.2 ± 5.0% visfatin + U0126, 48.2 ± 3.0% wortmannin, 49.2 ± 9.0% U0126; P > 0.05).